50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
NASDAQ:LHCG

LHC Group - LHCG Stock Forecast, Price & News

$164.31
-0.21 (-0.13%)
(As of 09/27/2022 05:10 PM ET)
Add
Compare
Today's Range
$163.79
$165.07
50-Day Range
$160.75
$164.74
52-Week Range
$108.42
$169.84
Volume
290,580 shs
Average Volume
428,199 shs
Market Capitalization
$5.10 billion
P/E Ratio
69.33
Dividend Yield
N/A
Price Target
$167.00

LHC Group MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1.5% Upside
$167.00 Price Target
Short Interest
Bearish
9.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
13.28%
From $4.97 to $5.63 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.54 out of 5 stars

Medical Sector

1001st out of 1,071 stocks

Home Health Care Services Industry

8th out of 9 stocks

LHCG stock logo

About LHC Group (NASDAQ:LHCG) Stock

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Receive LHCG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHCG Stock News Headlines

LHC Group Inc - Stock News
LHC Group is Now Oversold (LHCG)
LHC Group (LHCG) Q1 Earnings Surpass Estimates
LHC Group Tops Q1 EPS by 4c
Company News for Mar 30, 2022
LHC (LHCG) Moves 5.9% Higher: Will This Strength Last?
Optum And LHC Group To Combine
See More Headlines
Receive LHCG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHCG Company Calendar

Last Earnings
8/03/2022
Today
9/27/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NASDAQ:LHCG
CUSIP
50187A10
Employees
30,000
Year Founded
1994

Price Target and Rating

Average Stock Price Forecast
$167.00
High Stock Price Forecast
$185.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
+1.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

Net Income
$115.73 million
Pretax Margin
5.24%

Debt

Sales & Book Value

Annual Sales
$2.22 billion
Cash Flow
$7.50 per share
Book Value
$52.17 per share

Miscellaneous

Free Float
29,664,000
Market Cap
$5.10 billion
Optionable
Optionable
Beta
0.49

Social Links


Key Executives

  • Mr. Keith G. Myers (Age 63)
    Co-Founder, CEO & Chairman
    Comp: $1M
  • Mr. Joshua L. Proffitt (Age 44)
    Pres & Chief Operating Officer
    Comp: $663k
  • Mr. Dale Gerard Mackel (Age 57)
    Exec. VP, CFO & Treasurer
    Comp: $505.24k
  • Mr. Nicholas Gachassin IIIMr. Nicholas Gachassin III (Age 55)
    Exec. VP & Gen. Counsel
    Comp: $418.46k
  • Mr. Bruce D. Greenstein B.S. (Age 53)
    M.S., Exec. VP and Chief Strategy & Innovation Officer
    Comp: $546.8k
  • Mr. John L. Indest (Age 70)
    Consultant & Independent Director
    Comp: $101.5k
  • Ms. Kimberly S. Seymour (Age 45)
    Sr. VP & Chief Accounting Officer
  • Mr. Mohammad Ali
    Chief Information Officer
  • Mr. Marcus D. Macip
    Exec. VP & Chief Admin. Officer
  • Ms. JoAnne Little
    Sr. VP & Chief Compliance Officer













LHCG Stock - Frequently Asked Questions

Should I buy or sell LHC Group stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 10 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" LHCG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LHCG, but not buy additional shares or sell existing shares.
View LHCG analyst ratings
or view top-rated stocks.

What is LHC Group's stock price forecast for 2022?

10 equities research analysts have issued 1 year target prices for LHC Group's stock. Their LHCG share price forecasts range from $150.00 to $185.00. On average, they predict the company's stock price to reach $167.00 in the next twelve months. This suggests a possible upside of 1.5% from the stock's current price.
View analysts price targets for LHCG
or view top-rated stocks among Wall Street analysts.

How have LHCG shares performed in 2022?

LHC Group's stock was trading at $137.23 at the beginning of the year. Since then, LHCG stock has increased by 19.9% and is now trading at $164.52.
View the best growth stocks for 2022 here
.

When is LHC Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our LHCG earnings forecast
.

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings data on Wednesday, August, 3rd. The health services provider reported $0.98 EPS for the quarter, missing the consensus estimate of $1.32 by $0.34. The health services provider had revenue of $576.19 million for the quarter, compared to the consensus estimate of $598.94 million. LHC Group had a net margin of 3.20% and a trailing twelve-month return on equity of 8.88%.

What is Keith G. Myers' approval rating as LHC Group's CEO?

524 employees have rated LHC Group Chief Executive Officer Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among the company's employees.

What other stocks do shareholders of LHC Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

Who are LHC Group's major shareholders?

LHC Group's stock is owned by a variety of retail and institutional investors. Top institutional investors include State Street Corp (3.11%), Alpine Associates Management Inc. (2.67%), Versor Investments LP (1.99%), Westchester Capital Management LLC (1.72%), BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp (1.68%) and Geneva Capital Management LLC (1.48%). Insiders that own company stock include Nicholas Gachassin III, Ronald T Nixon and W Earl Reed III.
View institutional ownership trends
.

How do I buy shares of LHC Group?

Shares of LHCG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $164.52.

How much money does LHC Group make?

LHC Group (NASDAQ:LHCG) has a market capitalization of $5.11 billion and generates $2.22 billion in revenue each year. The health services provider earns $115.73 million in net income (profit) each year or $2.37 on an earnings per share basis.

How many employees does LHC Group have?

The company employs 30,000 workers across the globe.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The official website for the company is www.lhcgroup.com. The health services provider can be reached via phone at (337) 233-1307, via email at eric.elliott@lhcgroup.com, or via fax at 337-235-8037.

This page (NASDAQ:LHCG) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.